News
Update on Therapeutic Options for Myelofibrosis
New Treatments, New Challenges in the Treatment of Bladder and Renal Cancers
Advanced Gastric and Colorectal Cancer Diagnosis and Treatment
Treatment Selection and Symptom Management After MDS/MDN Diagnosis
Pivotal Studies Lead to New Treatment Landscape for Metastatic HER2-Positive Breast Cancer
Updates in Targeted Therapies, Management Strategies for Non-Small Cell Lung Cancer
Achieving, Managing Patient Care During Maintenance Therapy for AML
Racial Differences Influence Breast Cancer Risk Management in White, Black Women
Periadjuvant Pembrolizumab Improves EFS in Resectable Melanoma
Novel Treatment Approach May Reduce Risk of Death From ICI-Related Myocarditis
Gemcitabine, Docetaxel a Viable Alternative to BCG in Bladder Cancer
Fear of Cancer Recurrence Therapy Improved Outcomes for Survivors of Cancer
CAR T Outcomes by Poverty and Opportunity
Insurance Status Mediates Racial, Ethnic Inequities in Cervical Cancer
ONA Summit Highlights Collaboration, How Oncology Nurses Thrive Under Pressure
Outcomes in Extensive-Stage Small Cell Lung Cancer Based on Trial Eligibility
Factors Linked to Worse CAR-T Outcomes in High-Risk Multiple Myeloma
Artificial Intelligence Can Predict Cancer Survival Using Data From a Single Consultation
Genetic Susceptibility to Ovarian Cancer Does Not Modify Protective Effect of Aspirin
Featured
-
ONA Summit 2023
Coverage from the 2023 Oncology Nurse Advisor Summit. -
Sexual Health and Cancer: What Providers Need to Know
Sexual dysfunction may be common in cancer patients and survivors, but their sexual health is often overlooked. -
Intensified ADT for Recurrent High-Risk Prostate Cancer Beneficial
Intensified ADT with apalutamide, with or without abiraterone plus prednisone, for 52 weeks prolonged PSA progression-free survival compared with ADT alone among men with high-risk biochemically recurrent prostate cancer following radical prostatectomy. -
Improving Patient-Centered Care After Urinary Diversion
This report reviews the challenges patients with bladder cancer experience related to cystectomy and urinary diversion surgery. -
Improving End-of-Life Discussions With Cancer Patients
Timely discussions about end-of-life preferences can ensure patients with advanced cancer receive care that aligns with their goals, experts say.
Features
Aggregating Data Hides Cancer Disparities Affecting Asian and NHPI Patients in the US
Medical Aid in Dying: What Oncology Providers Need to Know
Seizing Opportunities: Easing Discomfort of Intravesical Therapy for Bladder Cancer
Advisor Forum
Concurrent Use of Cannabis May Reduce Efficacy of ICI Therapy
Observations suggest that concurrent use of cannabis with immune checkpoint inhibitors should be discouraged until more information is available.
Advising Patients With Cancer About COVID-19 Vaccination
What should patients with cancer be told about getting a COVID-19 vaccine?
Treatment Delays During COVID-19 Outbreak
Is there any guidance on which patients may be able to delay chemotherapy during the COVID-19 outbreak?
Drug Lookup
Search our drug information database which contains an extensive list of drugs.
Powered By : 
Fact Sheets
Palliative Care in Cancer (Fact Sheet)
What is palliative care? Palliative care is care given to improve the quality of life of patients who have a serious or life-threatening disease, such as cancer. Palliative care is an approach to care that addresses the person as a whole, not just their disease. The goal is to prevent or treat, as early as…
HIV Infection and Cancer Risk (Fact Sheet)
This fact sheet examines the impact of the human immunodeficiency virus (HIV) on cancer risk.
Challenges Faced By Oncology Nurses
Editorial Board
Eucharia Borden, MSW, LCSW, OSW-CAnn J. Brady, MSN, RN-BC, CHPN
Jiajoyce R. Conway, DNP, CRNP, AOCNP
Marianne Davies, DNP, ACNP, AOCNP
Frank dela Rama, RN, MS, AOCNS
Leah A. Scaramuzzo, MSN, RN-BC, AOCN
Lisa A. Thompson, PharmD, BCOP
Rosemarie A. Tucci, RN, MSN, AOCN
Kara M.L. Yannotti, MMH, BSN, RN, CCRP
- Loading...
Loading...
Loading... 
Loading...